---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-114916"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T07:02:43.199374+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics completes $3M share repurchase from InvaGen; two directors resign

## Summary
- Completed $3M repurchase of InvaGen's 100% stake in Avenue, financed by public offering closed Oct 11, 2022.
- Jaideep Gogtay, M.D. and E. Garrett Ingram resigned from Board and all committees effective Oct 31, 2022.
- Resignations not due to any disagreement with Company, its operations, or management.
- All rights granted to InvaGen under 2018 Stockholders Agreement terminated upon share repurchase.

## SEC filing metadata
- accession: 0001104659-22-114916
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/tm2229761d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-114916
- JSON: https://secwatch.observer/filing/0001104659-22-114916.json
- Plain text: https://secwatch.observer/filing/0001104659-22-114916.txt

## Key facts
- Executive change
  Jaideep Gogtay, M.D. resigned as Director at AVENUE THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm
- Executive change
  E. Garrett Ingram resigned as Director at AVENUE THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.